ImmunityBio, Inc.
USD8.76
-0.01 (-0.12%)
CEO
Richard Gerald Adcock
IPO Date
2015-07-28
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$8.80
Prev. Close
$8.77
Day Low
$8.56
Day High
$9.00
52W Low
$1.95
52W High
$12.43
Market Cap
$9.17B
Volume
6.79M
| -4.3 |
| 31 Dec 2023 | FY | 100.0% | -93761.4% | 99.4% | -115.6% | -1.24 | 5.05 | -4.4 |
| 31 Dec 2022 | FY | 100.0% | -173569.6% | 93.1% | -115.0% | -1.62 | 0.28 | -4.9 |
| 31 Dec 2021 | FY | 100.0% | -37129.6% | 143.2% | -74.0% | -2.67 | 0.91 | -6.8 |
| 31 Dec 2020 | FY | 100.0% | -36669.6% | 185.2% | -100.2% | -2.30 | 1.64 | -23.0 |
| 31 Dec 2019 | FY | -20858.1% | -152997.7% | -54.5% | -46.0% | 0.12 | 4.82 | -22.1 |
| 31 Dec 2018 | FY | 6717.0% | -204736.2% | -65.9% | -52.9% | 0.05 | 3.26 | -3.9 |
| 31 Dec 2017 | FY | 100.0% | -214273.3% | -44.1% | -38.5% | 0.03 | 6.35 | -14.7 |
| 31 Dec 2016 | FY | 100.0% | -274565.9% | -41.2% | -38.1% | 0.03 | 16.34 | -15.6 |
| -7.9 |
| 30 Sept 2025 | Q3 | 87.1% | -209.8% | 12.8% | -13.0% | -1.03 | 5.77 | -8.7 |
| 30 Jun 2025 | Q2 | 99.5% | -350.3% | 16.2% | -23.0% | -0.94 | 4.11 | -6.3 |
| 31 Mar 2025 | Q1 | 99.6% | -784.9% | 21.9% | -42.7% | -0.89 | 2.22 | -5.0 |
| 31 Dec 2024 | Q4 | 100.0% | -783.4% | 12.1% | -15.4% | -1.03 | 3.36 | -7.9 |
| 30 Sept 2024 | Q3 | 100.0% | -1404.0% | 11.5% | -23.5% | -1.00 | 2.68 | -7.5 |
| 30 Jun 2024 | Q2 | 100.0% | -12852.3% | 19.3% | -30.3% | -1.05 | 3.91 | -8.0 |
| 31 Mar 2024 | Q1 | 100.0% | -335272.5% | 19.4% | -33.5% | -1.06 | 3.64 | -6.7 |
| 31 Dec 2023 | Q4 | 100.0% | -167907.9% | 39.8% | -46.3% | -1.24 | 5.05 | -3.2 |